It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
The novel coronavirus disease (COVID-19) first described in Wuhan, China in December 2019, rapidly spread across the world and has become a global public health emergency. The literature on the neurological manifestations of COVID-19 is limited. We report a 24-year-old male who presented with vertigo, dysarthria and bradyphrenia 3 weeks after being diagnosed with COVID-19 on nasopharyngeal RT-PCR. The patient was diagnosed with acute cerebellitis based on MRI features and showed improvement post treatment with I.V methylprednisone for five days. The scope of this article is to highlight the importance of early identification of neurological symptoms and timely management as the outcomes may be catastrophic.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer